ISLAMABAD: Federal Minister for National Health Services, Regulations and Coordination Syed Mustafa Kamal will inaugurate the Pak Pharma & Healthcare Expo 2026 as chief guest on August 12 at 11:00am at Tulip Marquee, Murree Road, Islamabad.
The two-day international exhibition and conference, being organised by Prime Event Management, will continue from August 12 to 13, 2026. The event will bring together pharmaceutical and healthcare industry leaders, manufacturers, professionals, business representatives, regulators and other key stakeholders from Pakistan and abroad.
Kamran Abbasi, Director of Prime Event Management and organiser of the Pak Pharma & Healthcare Expo, said the exhibition was aimed at bringing key stakeholders of Pakistan’s pharmaceutical and healthcare sectors on a common platform.
He said the Expo would provide opportunities for interaction among manufacturers, suppliers, healthcare professionals, industry associations, regulators and decision-makers, while promoting new technologies, business linkages, investment and collaboration in the sector.
The Expo will showcase pharmaceutical processing and packaging machinery, laboratory and testing equipment, raw materials and active pharmaceutical ingredients, medical diagnostic equipment, hospital equipment and consumables, medicines and healthcare products, and surgical instruments.
The event is supported by the Pakistan Pharmaceutical Manufacturers’ Association (PPMA), Rawalpindi Chamber of Commerce and Industry (RCCI), Sarhad Chamber of Commerce and Industry (SCCI), Pakistan Pharmacists Association (PPA), and Nutraceutical Manufacturers Association of Pakistan (NMAP).
In a significant regulatory engagement alongside the Expo, the Drug Regulatory Authority of Pakistan (DRAP) has announced dedicated interaction sessions with the pharmaceutical and healthcare industry. According to an official communication issued by the CEO Secretariat of DRAP, the sessions are aimed at promoting regulatory awareness, transparency and meaningful engagement with industry stakeholders.
DRAP said the sessions would apprise the industry of key regulatory requirements and expectations, while providing industry representatives an opportunity to seek clarifications and raise matters of common interest through structured discussions. The sessions will also include question-and-answer segments.
The regulatory sessions will cover important topics, including the responsibilities of pharmaceutical manufacturers under pharmacovigilance rules, common deficiencies in registration applications and regulatory expectations, and the regulatory framework and industry preparedness under the Alternative Medicines and Health Products Rules 2026.
DRAP has also asked major organisations in the pharmaceutical, nutraceutical and healthcare sectors to encourage their member companies and relevant representatives to participate in the sessions and submit questions and issues of wider industry importance. The authority said continued and constructive engagement with industry was important for regulatory clarity, improved compliance and effective implementation of regulatory requirements.
Prominent regulatory, industrial and business figures expected to attend as special guests include DRAP Chief Executive Officer Dr Ubaidullah; Bio Labs (Pvt) Ltd Managing Director, PPMA North Chairman and RCCI President Usman Shaukat; Herbiotics Healthcare CEO and NMAP founder and chairman Muhammad Danish Khan; PPA President and Deputy Secretary, Department of Health and Population, Government of Punjab, Muhammad Alamgir Rao; and SCCI President Junaid Altaf.
The Expo is expected to provide stakeholders in the pharmaceutical and healthcare sectors an important platform to learn about new technologies, strengthen professional and business linkages, exchange knowledge and experience, and explore opportunities for cooperation and investment.
Local and foreign exhibitors are expected to participate in the two-day exhibition, which will highlight new developments, regulatory priorities and emerging business and investment opportunities in Pakistan’s pharmaceutical and healthcare industry.
